Article
FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
Annals of hematology - 1 Nov 2012
Ghosh Kanjaksha, Swaminathan Suchitra, Madkaikar Manisha, Gupta Maya, Kerketta Lily, Vundinti Baburao
Abstract excerpt
Acute myeloid leukemia (AML) is an aggressive hematological disorder characterized by the loss of ability of the hematopoietic progenitor cells to differentiate and proliferate normally leading to an accumulation of immature myeloid cells in the bone marrow. Several novel molecular genetic aberrations in FLT3 and NPM1 have been shown to have a prognostic impact in AML, particularly in those having normal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
